New media solution enables brands to win discoverability, visibility, positive sentiment, and outcomes across major AI systems NEW YORK, NY AND LONDON, UK / ACCESS Newswire / March 2, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced the global launch of Stagwell Search+, the industry's first agentic platform for AI Search experiences. Built by Assembly, Stagwell's global omnichannel media agency, in partnership with Emberos, the operating system ...

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026. Fluent will host a conference call at 4:30 p.m. ET on the same day to discuss the results. The conference call can be accessed by phone after registering online at Fluent Conference Call or via audio at Audio Registration. The call and accompanying slide prese ...

Celebration, FL, March 02, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today released the following letter to shareholders from its CEO, Joseph La Rosa. To our valued shareholders, Since the beginning of the year, we have taken deliberate and disciplined steps to reposition La Rosa for the next phase of its evolution, one defined by digital infrastructure, artificial intelligence, and operational efficiency. Most notably ...

[https://mma.prnewswire.com/media/2319310/IceCure_Medical_Logo.jpg]SOURCE IceCure Medical## 21% [more press release views with Request a Demo]## Also from this source### IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026[IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that...]### IceCure Announces Thomas Hos ...

FORT PIERCE, FL / ACCESS Newswire / March 2, 2026 / Twin Vee PowerCats Co. (Nasdaq:VEEE),("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today reported financial results for the year ended December 31, 2025, and provided a business update. According to the Company, fiscal 2025 marked a transition year for Twin Vee, as management executed a comprehensive operational reset. ...

WARWICK, NY, March 02, 2026 (GLOBE NEWSWIRE) -- OZOP Energy Solutions, Inc. (OTC: OZSC, “Company”) today highlighted the addition of Ty Gilmore to the commercial leadership team of Varon. Mr. Gilmore will serve as Chief Revenue Officer of Varon. He is a seasoned beverage industry executive with more than two decades of experience across national accounts, distribution, and operational leadership at large-scale, multi-billion-dollar consumer packaged goods companies. Most recently, Mr. Gilmore served as Pres ...

MINNEAPOLIS, March 02, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the schedule of scientific presentations reviewing the science and outcomes of Barostim therapy at the Technology and Heart Failure Therapeutics 2026 (THT) meeting. THT, the annual conference organized by the Cardiovascular Research Foundation® (CRF®), will b ...

COLORADO SPRINGS, CO / ACCESS Newswire / March 2, 2026 / Fortitude Gold Corp. (OTCQB:FTCO) (the "Company") announced that it has entered into a Joint Venture Agreement (the "JV Agreement") with Hawthorne Land & Minerals, LLC ("Hawthorne") to accelerate the exploration and development of its East Camp Douglas property located in Mineral County, Nevada. Pursuant to the JV Agreement, the parties will form an operating subsidiary, East Camp Douglas, LLC (the "JV"), which will be funded through a strategic $40 m ...

In the Phase 3 AFFIRM study in adults with moderately to severely active Crohn's disease, risankizumab (SKYRIZI®) achieved superiority for the co-primary and ranked secondary endpoints at week 12 for induction delivered by subcutaneous (SC) injection versus placebo1 These data support strong efficacy of risankizumab in Crohn's disease while providing potential for an induction choice for patients1 The safety profile of risankizumab SC induction was consistent with its known profile in Crohn's disease, wi ...

HAUPPAUGE, N.Y., March 02, 2026 (GLOBE NEWSWIRE) -- Dime announced today the elevation of Charlie Terrasi to Head of Investor Commercial Real Estate and Multifamily. Mr. Terrasi will manage and oversee growth in the Company’s Investor CRE portfolio, in addition to his current oversight of the multifamily portfolio. Stuart H. Lubow, CEO and President, stated, "As a result of Charlie's successful leadership and management of the Bank’s multifamily portfolio, he will take on the additional responsibility of le ...